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Abstract
Cornelia de Lange Syndrome (CdLS) is a multi-organ system birth defects disorder linked, in at least half of cases, to
heterozygous mutations in the NIPBL gene. In animals and fungi, orthologs of NIPBL regulate cohesin, a complex of proteins
that is essential for chromosome cohesion and is also implicated in DNA repair and transcriptional regulation. Mice
heterozygous for a gene-trap mutation in Nipbl were produced and exhibited defects characteristic of CdLS, including small
size, craniofacial anomalies, microbrachycephaly, heart defects, hearing abnormalities, delayed bone maturation, reduced
body fat, behavioral disturbances, and high mortality (75–80%) during the first weeks of life. These phenotypes arose
despite a decrease in Nipbl transcript levels of only ,30%, implying extreme sensitivity of development to small changes in
Nipbl activity. Gene expression profiling demonstrated that Nipbl deficiency leads to modest but significant transcriptional
dysregulation of many genes. Expression changes at the protocadherin beta (Pcdhb) locus, as well as at other loci, support
the view that NIPBL influences long-range chromosomal regulatory interactions. In addition, evidence is presented that
reduced expression of genes involved in adipogenic differentiation may underlie the low amounts of body fat observed
both in Nipbl+/2 mice and in individuals with CdLS.
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Introduction
Cornelia de Lange Syndrome (CdLS; OMIM#122470) is
characterized by developmental abnormalities of the cardiopul-
monary, gastrointestinal, skeletal, craniofacial, neurological, and
genitourinary systems [1–3]. The clinical presentation ranges from
subtle dysmorphology to conditions incompatible with postnatal
life. Common structural birth defects observed in CdLS include
upper limb reduction (significant in just under half of cases),
cardiac abnormalities (especially atrial and ventricular septal
defects), and craniofacial dysmorphia (including dental and middle
ear abnormalities, occasional clefting of the palate, and highly
characteristic facies) [2–8]. Other findings include small head size,
lean body habitus, hirsutism, ophthalmologic abnormalities, pre-
and postnatal growth retardation, and structural abnormalities of
the gastrointestinal tract (duodenal atresia, annular pancreas, small
bowel duplications) [2,3,9–11]. Physiological disturbances in
CdLS include moderate to severe mental retardation [12] often
accompanied by autistic behaviors [13], and severe gastrointestinal
reflux [14]. Although prevalence has been estimated at between
,1/10,000 and 1/50,000 births [8,15], wide phenotypic variabil-
ity in the syndrome makes it likely that large numbers of mildly-
affected individuals are not being counted.
A genetic basis for CdLS was uncovered in 2004 with the
demonstration that many affected individuals carry mutations in
Nipped-B-like (NIPBL), so named for its homology to the Drosophila
gene, Nipped-B [16,17]. Heterozygous NIPBL mutations are found
in about 50% of individuals with CdLS [18]. As many of these
mutations are expected to produce absent or truncated protein,
haploinsufficiency is the presumed genetic mechanism [19].
NIPBL/Nipped-B protein is found in the nuclei of all eukaryotic
cells, where it interacts with cohesin, the protein complex that
mediates sister chromatid cohesion [20,21]. The NIPBL ortholog
in fungi plays a role in loading cohesin onto chromosomes, and a
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minority of cases of mild CdLS result from mutations in the
SMC1L1/SMC1A (,5%; OMIM 300590) and SMC3 (1 case;
OMIM 610579) genes, which encode two of the four cohesin
structural components, supports the view that CdLS is caused by
abnormal cohesin function [22,23]. Consistent with the hypothesis
that cohesin plays important roles during embryonic development,
it was found that mutations in the cohesin regulatory protein
ESCO2 cause Roberts’-SC phocomelia syndrome, another multi-
organ systems birth defects syndrome [24,25]. In mice, deletion of
the cohesin regulators PDS5A and PDS5B also produces a wide
variety of developmental defects, some of which overlap with
CdLS [26,27]. In addition, there has recently been a report of one
family showing atypical inheritance of CdLS, in which both
affected and unaffected siblings harbor a missense mutation in the
PDS5B gene, raising the possibility of some genetic association
between PDS5B and CdLS [27].
How alterations in cohesin function give rise to pervasive
developmental abnormalities is largely unknown. Cohesin is involved
in sister chromatid cohesion and DNA repair in many organisms, but
observed alterations in cohesion and repair in individuals with CdLS
are mild at best [28,29]. More recently, observations in model
organisms and cultured cells have suggested that cohesin plays
important roles in the control of transcription [reviewed in 18]. In
Drosophila, for example, changes in levels of Nipped-B or cohesin
structural components alter the expression of developmental
regulator genes, such as homeodomain transcription factors [30–
33]. Such effects on gene expression, which have been proposed to
reflect the disruption of long-range promoter-enhancer communica-
tion, occur with small changes in Nipped-B or cohesin levels that do
not produce cohesion defects; they can also occur in postmitotic cells,
in which chromosome segregation is presumably not an issue [18].
Studies using Drosophila cell lines have demonstrated that cohesin
and Nipped-B binding are concentrated near the promoters of
active transcriptional units [34]. In mammalian cells, cohesin often
binds, in an NIPBL-dependent manner, to sites occupied by the
transcriptional insulator protein CTCF, where it plays a significant
role in CTCF function [35–37]. Recently, NIPBL has also been
shown to bind and recruit histone deacetylases to chromatin [38].
These observations suggest that cohesin and NIPBL may interact in
multiple ways with the transcriptional machinery.
As a first step toward understanding the molecular etiology of
CdLS, we generated a mouse model of Nipbl haploinsufficiency,
which replicates a remarkable number of the pathological features
of CdLS. Cellular and molecular analysis of mutant cells and
tissues revealed widespread, yet subtle, changes in the expression
of genes, some of which are found in genomic locales in which
transcription is known to be controlled through long-range
chromosomal interactions. We propose that the aggregate effects
of many small transcriptional changes are the cause of develop-
mental abnormalities of CdLS, and present evidence that one set
of transcriptional changes may explain the notably lean body
habitus of many individuals with CdLS.
Results
Heterozygous mutation of Nipbl is associated with
perinatal mortality
Two mouse ES cell lines bearing gene-trap insertions into Nipbl
were obtained and injected into C57BL/6 blastocysts to produce
chimeras (see Materials and Methods). Male chimeras were bred
against both inbred (C57BL/6) and outbred (CD-1) mice. For only
one cell line (RRS564, which contains a beta-geo insertion in
intron1, and is predicted to produce a truncated transcript with no
open reading frame; Figure S1) was ES cell contribution to the
germline obtained (as scored by coat color; Table 1). Whereas
Mendelian inheritance predicts that half the germline progeny of
chimeric mice should be heterozygous (Nipbl+/2) for the gene trap
insertion, the observed frequency was much lower. When
chimeras were bred against CD-1 females, 22 out of 113 germline
progeny (19%) carried the mutant allele (Table 1). With C57BL/6
females only one out of 18 germline progeny carried the mutation
(5.5%), and this animal, although male, did not produce any
progeny when subsequently mated.
In view of these data, it was decided that further analysis of the
Nipbl2 allele would take place through outcrossing onto the CD-1
background. As shown in Table 1, when the Nipbl+/2 offspring of
chimera by CD-1 crosses (N0 generation) were bred against
wildtype (CD-1) females, 17% of surviving adult progeny carried
the mutant allele. When animals of this ‘‘N1 generation’’ were
again outcrossed against CD-1, 18% of surviving progeny (N2)
carried the mutant allele. Similar survival ratios were observed for
subsequent generations of outcrossing.
The data imply that 75–80% of Nipbl+/2 mice die prior to
genotyping (typically done at 4 weeks of age), a fraction that
remains stable as the mutant allele is progressively outcrossed onto
the CD-1 background. To determine whether lethality occurs in
utero, we examined litters for Nipbl+/2 embryos just before birth
(gestational days E17.5 and E18.5). With no visible marker
available for the ES-cell derived progeny of chimeras, this test was
carried out with progeny of the N0 generation, in which the
Mendelian expectation for the mutant allele is 50%. Mutants were
found to comprise 41% (30 out of 67) of progeny, a frequency not
significantly different from expected for this sample size (Table 1).
These data imply that most mutants die at or after birth.
Abnormal heart and bone development, and reduced
growth in Nipbl+/2 embryos
To evaluate the extent to which Nipbl+/2 mice provide a good
model for CdLS, we performed an analysis in which we examined
these animals for a number of different structural phenotypes
analogous to common clinical findings observed in CdLS
Author Summary
Cornelia de Lange Syndrome (CdLS) is a genetic disease
marked by growth retardation, cognitive and neurological
problems, and structural defects in many organ systems.
The majority of CdLS cases are due to mutation of one
copy of the Nipped B-like (NIPBL) gene, the product of
which regulates a complex of chromosomal proteins called
cohesin. How reduction of NIPBL function gives rise to
pervasive developmental defects in CdLS is not under-
stood, so a model of CdLS was developed by generating
mice that carry one null allele of Nipbl. Developmental
defects in these mice show remarkable similarity to those
observed in individuals with CdLS, including small stature,
craniofacial abnormalities, reduced body fat, behavioral
disturbances, and high perinatal mortality. Molecular
analysis of tissues and cells from Nipbl mutant mice
provide the first evidence that the major role of Nipbl in
the etiology of CdLS is to exert modest, but significant,
effects on the expression of diverse sets of genes, some of
which are located in characteristic arrangements along the
DNA. Among affected genes is a set involved in the
development of adipocytes, the cells that make and
accumulate body fat, potentially explaining reductions in
body fat accumulation commonly observed in individuals
with CdLS.
Mouse Model of Cornelia de Lange Syndrome
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features of CdLS are small body size, often evident before birth;
heart defects; and upper limb abnormalities ranging from small
hands to frank limb truncations [2–5,7,8,39]. As shown in Table 2,
Nipbl+/2 embryos examined shortly before birth (E17.5–E18.5)
were 18–19% smaller than wildtype littermates (P,0.001), a
reduction not accompanied by decreased placental size. Nipbl+/2
embryos at earlier stages were also noted to be slightly smaller than
littermates (data not shown).
Nipbl+/2 embryos did not display limb or digit truncations, or
obvious loss of any other bony elements. However, upon staining
embryonic skeletons, we observed delays in ossification of both
endochondral and membranous bones of Nipbl+/2 embryos. As
shown in Figure 1A–1D, delayed ossification of the skull and digits
was apparent between E16.5 and E18.5. Measurement of long
bones and digits at E17.5 revealed, in addition to a symmetrical
reduction in bone length (consistent with smaller body size), a
significant decrease in the relative extent of ossification (Figure 1E).
Otherwise, the patterning of cartilaginous elements was relatively
normal, although some subtle differences in morphology were
consistently observed, e.g. the shape of the olecranon process of
the ulna was consistently abnormal in Nipbl+/2 mouse embryos
(Figure 1F–1G). Interestingly, dys- and hypoplastic changes of the
ulna are common findings in CdLS [40].
Among the cardiac defects that occur in CdLS, atrial and
ventricular septal defects are especially common [2,5,7]. Atrial
septal defects, which were typically large, were observed in about
half of Nipbl+/2 mouse embryos, (Figure 1H–1K; Table S1), and
could be detected as early as E15.5, shortly after atrial septation
normally finishes. A reduction in atrial size was also seen in some
mutants, but was not a consistent finding. No defects were
detected in the atrioventricular valves or septum, outflow tract, or
pulmonary vasculature. However, many mutant embryos dis-
played subtle abnormalities of the ventricular and interventricular
myocardium, including abnormal lacunar structures and disorga-
nization of the compact layer, especially near the apex (data not
shown). Significantly, no histological or functional cardiac
abnormalities were detected among mutant mice that survived
the perinatal period (data not shown). This implies that the cause
of perinatal mortality is either cardiac, or correlates strongly with
the presence of cardiac structural defects.
Histological examination of other organ systems in late
embryonic mutant mice revealed no obvious anatomical abnor-
malities of the lungs, diaphragm, liver, stomach, spleen, kidney or
bladder. Brains of neonatal Nipbl+/2 mice displayed relatively
normal gross anatomy, although a single mutant was observed to
have a large brainstem epidermoid cyst (not shown).
Surviving mutant mice are small, and fail to thrive
Most Nipbl+/2 mice that survived the perinatal period reached
adulthood, and appeared to have a normal lifespan. However,
marked decrease in the body size of mutant mice was evident at
birth and throughout all ages (Figure 2A and 2B). Indeed, the 18–
19% weight difference between mutant and wildtype mice
observed before birth (Table 2) widens to 40–50% by postnatal
weeks 3–4 (Figure 2C–2E; this finding has remained consistent
over 6 generations [data not shown]). To investigate early
postnatal growth of Nipbl+/2 mice in more detail, litters fathered
by N1 and N2 generation animals were subjected to daily weighing
from shortly after birth until sexual maturity (5–6 weeks of age;
Figure 2F). Most mutant mice exhibited failure to thrive during the
first weeks of life, with many undergoing several days of wasting
Table 2. Prenatal growth retardation in Nipbl+/2 embryos.
Genotype E17.5 Body weight (g) E17.5 Placental weight (g) E18.5 Body weight (g)
Mean S.D. N Mean S.D. N Mean S.D. N
+/+ 1.02 0.096 30 0.115 0.015 23 1.27 0.076 7
Nipbl+/2 0.80* 0.115 23 0.112{ 0.024 17 1.00* 0.082 7
Embryos were obtained at the indicated times from crosses of N0 Nipbl+/2 males and CD-1 females. Reduction in weight of 18–19% in mutant embryos is apparent at
both ages, without a significant difference in placental weight.
*P,0.001.
{P=0.64, by Student’s t-test.
doi:10.1371/journal.pgen.1000650.t002
Table 1. Heterozygosity for Nipbl causes postnatal lethality.
Paternal genotype Surviving$3 postnatal weeks Viable at E17.5–E18.5 Resorption at E17.5
+/++ /2 ratio +/++ /2 ratio +/++ /2
Chimera 91 22 4.1:1* nd nd nd nd nd
N0 Nipbl+/2 190 40 4.8:1* 37 30 1.2:1{ 02
N1 Nipbl+/2 247 54 4.6:1* nd nd nd nd nd
Data are presented on the frequencies of genotypes resulting from crosses between heterozygous mutant males and CD-1 females. The males referred to in the first
row were the chimeras produced by injection of Nipbl+/2 ES cells into C57BL/6 blastocysts, so in this case only progeny descended from ES cells (as distinguished by
chinchilla coat color) were scored. Surviving Nipbl+/2 mice from these crosses are referred to as the N0 generation; their offspring with CD-1 females are referred to as
the N1 generation; their offspring with CD-1 females as the N2 generation; and so on. Note that although the ratio of mutant to wildtype animals at E17.5–E18.5 is not
significantly different from 1:1, the presence of identifiably-mutant, but not wildtype, resorbed embryos at this stage suggests that there may be a small amount of late
embryonic loss.
*P,0.001 by chi-squared analysis when compared with Mendelian expectations.
{P=0.67 compared with Mendelian expectations, and P,0.005 when compared with the postnatal distribution.
doi:10.1371/journal.pgen.1000650.t001
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weight of surviving mutants was only 40% of wildtype, but after
weaning this pattern abruptly changed: mutants (even ones that
had already begun to show wasting) underwent rapid catch-up
growth (Figure 2F), such that by 9 weeks of age they had reached
65–70% of wildtype weight. These observations suggest that, in
addition to being intrinsically small, Nipbl+/2 mice may have
difficulty with suckling, or may receive inadequate nutrition from
milk. Remarkably, the weights of children with CdLS also fall
further behind age norms during the first year of life, but show
significant catch-up growth later on [11].
Nipbl+/2 mice exhibit distinctive craniofacial changes
The distinctive craniofacial features of CdLS, including
microbrachycephaly, synophrys, upturned nose, and down-turned
lips, play an important role in clinical diagnosis [3,6]. Micro-CT
analysis was used to assess whether Nipbl+/2 mice also display
consistent craniofacial changes. Analysis of the skulls of 63 adult
mice showed significantly smaller size (microcephaly) among all
mutants (N=23), as well as a variety of significant shape changes
(Figure 3). The latter included foreshortening of the anterior-
posterior dimensions of the skull (i.e. brachycephaly) and an
upward deflection of the tip of the snout (Figure 3B–3E). The
upturned nares (Figure 3C and 3E) reflect reduced size of the
ethmoid and sphenoid bones, which produces a sunken midface.
Together, these shape changes in the basicranium and face are
consistent with a greater reduction in the size of chondrocranial, as
opposed to dermatocranial, elements within the skull. In addition,
an 8% average decrease in bone thickness was also observed
(ANOVA, df=47, F=18.6, p,0.01).
Neurological and physiological abnormalities of
postnatal Nipbl+/2 mice
Neurological abnormalities in CdLS include mental retardation,
abnormal sensitivity to pain, and seizures [41]. Although Nipbl+/2
mice have not been subjected to intensive long-term neurological
or behavioral tests, several distinctive behaviors were observed:
Repetitive circling (Videos S1, S2, S3) was noted in 20% (34/173;
15 females and 19 males) of adult Nipbl+/2 mice (.5 weeks of
age), across all generations examined (N0–N4). Repetitive
behaviors—including twirling in place [42]—are common symp-
toms in children with CdLS. In addition, 30% (4/13; all males) of
Nipbl+/2 mice were noted to adopt opisthotonic postures in
response to administration of a normal anesthetic dose of avertin
(see Materials and Methods), strongly suggesting seizure activity.
Seizures are also common in individuals with CdLS [43,44].
We also observed that 15% of Nipbl+/2 adult mice (24/158; 11
females and 13 males) displayed reflexive hindlimb clasping when
Figure 1. Abnormalities of bone and heart development in
Nipbl+/2 mice. (A,B) Cranial and trunk skeleton at E17.5, stained with
alcian blue/alizarin red (blue staining shows cartilage; red shows bone).
(A) Wildtype and (B) Nipbl+/2. Arrows indicate locations at which
ossification is delayed in the mutant. (C) Forepaws at E16.5. Skeletal
elements are patterned normally in the mutant, but are smaller. (D)
Forepaws at E18.5. Delayed ossification is readily seen in mutant
metacarpals and phalanges. Scale bars in (A–D)=2 mm. (E) Long bone
length and degree of ossification at E18.5. For each bone, wildtype
measurements are shown in the left bar, mutant in the right. The filled
portion of each bar depicts the ossified fraction of the bone. Data are
averaged independent measurements in each case (N=14 for most
measurements, with the exception of wildtype scapula [N=9], Nipbl+/2
scapula [N=13], and Nipbl+/2 femur [N=11]). In mutant animals, long
bones are ,10% shorter than wildtype, and the degree of ossification is
decreased by 5–7%. (F,G) Elbow joints of representative wildtype (F)
and mutant (G) embryos at E18.5. The olecranon process (arrow) is
longer and more pointed in the mutant. (H–K) Defects in cardiac
septum formation. The developing atrial septum primum and septum
secundum are readily apparent in wildtype heart at E15.5 [(H), arrow]
but reduced in Nipbl+/2 embryos at the same age (I). At E17.5, a well-
formed atrial septum is apparent in wildtype [(J), arrow], but absent in
many mutants (K). Scale bars in (G,I,K)=1 mm.
doi:10.1371/journal.pgen.1000650.g001
Mouse Model of Cornelia de Lange Syndrome
PLoS Genetics | www.plosgenetics.org 4 September 2009 | Volume 5 | Issue 9 | e1000650Figure 2. Growth of Nipbl+/2 mice. (A,B) Photographs of pairs of newborn (A) and 4 week old (B) wildtype and Nipbl+/2 littermates, illustrating
obvious growthretardation. (C–E)Growth curves forN0 (C), N1 (D), andN2 (E) generations, startingatweaning age. Dataarepooled bygenotype andsex
(N0 wildtype:15males and7 females; N0 Nipbl+/2 : 12males and7 females; N1 wildtype 39 males and28 females;N1 Nipbl+/2: 23 malesand17 females;
N2 wildtype: 72 males and 38 females, N2 Nipbl+/2: 39 males and 23 females): filled squares=male, open circles=female; red symbols=Nipbl+/2, black
symbols=wildtype; error bars=SEM. Mutant mice of both sexes are smaller, and exhibit less weight gain after maturity.(F) Growth from birth through 6
weeks. Wildtype data (black symbols and lines) are pooled by sex: filled squares=male, open circles=female (data from 28 females and 26 males. error
bars=SEM). The records of individual Nipbl+/2 mice (N2 and N3 generation) are shown as connected lines without symbols. Red lines represent
individual animals that survived at least 6 weeks (dashed=female; solid=male). Blue lines are Nipbl+/2 mice that died before weaning. Green lines
represent additional mice that died before weaning for which genotype could not be established (due to cannibalism or tissue decomposition). The
inset magnifies the pre-weaning interval (1 to 22 days). Whereas wildtype mice grow at a nearly linear rate during the first two weeks of life, the data
show that growth of most mutant mice arrests between postnatal days 5 and 15, followed, in about a third of cases, by death several days later. Several
of the mutants that stopped growing and lost weight after day 12, however, were able to resume rapid weight gain immediately after weaning.
doi:10.1371/journal.pgen.1000650.g002
Mouse Model of Cornelia de Lange Syndrome
PLoS Genetics | www.plosgenetics.org 5 September 2009 | Volume 5 | Issue 9 | e1000650Figure 3. Craniofacial alterations. Morphometric analysis of craniofacial morphology was based on micro-CT scans of 23 mutant and 40 wildtype
mice (N0 and N1 generation; mixed sexes, ages 218–373 days). (A) Representative reconstructions of wildtype and mutant skulls. From left to right,
dorsal, lateral, and ventral views are shown. (B) Average shapes for both genotypes, obtained as described by [131], using the entire sample of scans.
(C) Shape distance map [131], showing the distribution of shape effects of the mutation. (D) Results of Euclidean Distance Matrix Shape analysis. This
analysis compares the entire set of linear distances between landmarks to identify local differences in form. The two groups are significantly different
in shape by a Monte Carlo randomization test (p,0.001). Distances shown are those that differ .5% between groups. Red lines are distances that are
relatively smaller in the mutant; blue lines are those that are relatively larger. (E) Results of geometric morphometric analysis (Procrustes
superimposed) of craniofacial shape. In this form of analysis, the 3D landmarks representing each individual are scaled to remove size and then
superimposed using a translation and rotation step. This yields a dataset in which the differences in landmark position reflect differences in shape
independently of size. (i) Principal components analysis can be used to visualize the variation in such a dataset, by transforming a set of correlated
variables into a new set of uncorrelated ones, each representing successively smaller portions of the total sample variance. (ii) Variation along a
principal component can be represented as a deformation of a wireframe drawn using the landmarks. The first principal component (PC1)
distinguishes mutants from wildtypes. The two groups are also significantly different in shape by Goodall’s F-test and MANOVA (p,0.001). The first
principal component for the combined sample captures the shape variation that distinguishes the groups. The left panel indicates dorsal view of the
wireframe and the right indicates lateral view. Blue=wildtype, red=Nipbl+/2.
doi:10.1371/journal.pgen.1000650.g003
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littermates showed the same behavior (Table S1). Hindlimb
clasping has been observed in several mouse models of
neurological disorders, including Rett’s syndrome [45–47],
mucolipidosis type IV [48], infantile neuroaxonal dystrophy and
neurodegeneration with brain iron accumulation [49], and
Huntington’s disease [50–53].
Histological examination of mutant brains revealed the
presence of all major brain structures, grossly normal lamination
of the cerebral and cerebellar cortices, but an overall reduction in
brain size, consistent with a 25% reduction in endocranial volume
observed with micro-CT (Figure 4A, two-tailed T-test, df=28,
T=5.7 p,0.01). Absence or reduction in size of the corpus
callosum was occasionally observed in Nipbl+/2 mice (Figure 4B).
Obvious patterning defects were noted only in the midline
cerebellum, where lobe IX displayed specific reductions
(Figure 4C). Interestingly, midline cerebellar hypoplasia is one of
the few consistently-reported changes in brain anatomy in CdLS
[54–56].
Children with CdLS display a range of ophthalmological
abnormalities including ptosis, microcornea, nasolacrymal duct
obstruction, strabismus, blepharitis and conjunctivitis [57–59]. We
noted that 22% of Nipbl+/2 mice exhibited one or more gross
ophthalmological abnormalities (Table S1). Most frequently
observed was ocular opacification, observed in 14% of animals
(Figure 4D); opacities were often evident as early as three weeks of
age. In several cases, this condition was associated with marked
periorbital inflammation, and progressed to permanent closure of
the eyelids (not shown). Histological analysis revealed inflamma-
tory and fibrotic changes within the corneal epithelium and stroma
Figure 4. Neuroanatomical, ophthalmic, and auditory phenotypes. (A) Measurements from micro-CT analysis (Figure 3) reveal a 25%
reduction in endocranial volume in Nipbl+/2 mice (data are means6SD from 40 wildtype and 23 mutant skulls). (B) Nissl-stained coronal sections of
adult wildtype (+/+) and Nipbl+/2 brains illustrate reduced brain size, but grossly normal neuroanatomy. MHb, medial habenular nucleus; fr, fasiculus
retroflexus; mt, mammillothalamic tract; dg, dentate gyrus; cc, corpus callosum. Scale bar: 1 mm. (C) Cerebellar hypoplasia in Nipbl+/2 mice. Cresyl
violet-stained midsagittal sections through the cerebellum of adult wildtype and Nipbl+/2 mice. Mutant cerebella are smaller overall, with a less well-
developed folium IX (bracket); note the subfolium (arrow in +/+) that was missing in 100% of analyzed mutants (asterisk; N=3 Nipbl+/2 and 3
wildtype littermate controls assessed). Reduction in the size of folium I was also commonly observed in mutants (not shown). Scale bar: 500 mm. (D,E)
Corneal pathology in Nipbl+/2 mice. (D) External view of wildtype and Nipbl+/2 eyes, demonstrating central opacity (green arrowhead) and
swelling/inflammation in the periorbital area (arrows) in the mutant. (E) Sections through wildtype and Nipbl+/2 eyes, demonstrating disruption of
corneal structure in the mutant, including infiltration of cells into the stroma and loss of epithelium. Ocular opacification was observed in 14% (24/
173) of post-weaning animals tested. Scale bar: 100 mm. (F,G) Hearing deficits in Nipbl+/2 mice. (F) Auditory brainstem evoked response (ABR)
records for a pair of wildtype and Nipbl+/2 littermates, performed as described [62]. Stacked curves are responses to successive 10 dB increments of
a pure-tone stimulus, and display five characteristic peaks of differing latency. In the Nipbl+/2 curves, hearing loss is indicated by the much higher
response threshold (this is seen in less than half of mutants). (G) Average background-subtracted sizes of Peaks II, III, and IV (normalized to Peak I to
correct for experimental variation due to differences in electrode placement) for the 90 dB tone response of 6 wildtype and 6 mutant animals.
Mutants show marked depression of peak III (P,0.02, ANOVA), consistent with abnormalities at the level of the auditory nerve or brainstem.
doi:10.1371/journal.pgen.1000650.g004
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injury might arise from neglect due to abnormalities in corneal
sensation, from abnormal production or composition of tear fluid,
or secondary to periorbital inflammation or infection (e.g.
blepharitis; cf. Table S1).
Some degree of hearing loss is observed in almost all individuals
with CdLS, and this may play a role in the marked speech
disability often seen in this syndrome [60,61]. To assess hearing in
Nipbl+/2 mice, we measured auditory brainstem evoked responses
(ABR [62]). Abnormalities were found in the majority of mutant
mice examined (Table S1). In a few cases, markedly increased
thresholds to stimulation were observed (Figure 4F). More
commonly, stimulus thresholds were within normal limits, but
the relative intensities of the components of the ABR were altered.
In particular, mutant mice displayed a characteristic reduction in
the amplitude of the third peak (at about 3 msec following
stimulus), a latency consistent with an abnormality in the auditory
nerve and/or early brainstem neural pathways (Figure 4G).
Levels of Nipbl expression are reduced by only 25–30% in
Nipbl+/2 mice
The Nipbl
564 gene-trap mutation is expected to produce a
truncated message lacking all but the first exon (Figure S1).
Therefore, the level of full-length Nipbl mRNA in Nipbl+/2 mice
should provide an indication of the activity of the wildtype allele.
To measure this level, we used an RNase protection assay based
on hybridization to sequences found in exons 10 and 11. Total
RNA was analyzed from two tissues: adult liver and E17.5 brain,
using age-matched littermate controls. As shown in Figure 5, Nipbl
levels in mutants, as a percentage of wildtype levels, were 72–82%
in adult liver, and ,70% in embryonic brain. When western
blotting was used to quantify levels of NIPBL protein in Nipbl+/2
embryo fibroblasts (MEFs), a reduction to about 70% of wildtype
levels was observed (Figure S2).
The observation that Nipbl+/2 mice exhibit only a 25–30%
decrease in transcript and protein expression, rather than an
expected decrease of 50%, is consistent with Nipbl gene being
autoregulatory. An alternative explanation is that the mutant allele
is ‘‘leaky’’, i.e. alternative splicing around the gene trap cassette
produces some wildtype message. We favor the former explanation
because, in both Drosophila and man, the evidence indicates that null
mutation of a single allele of Nipped-B/NIPBL produces only a
25–30% drop in transcript levels, the same decrease we observe in
Nipbl+/2 mice[31,63,64]. Thus, even if theNipbl allele studied here
is not null, it is probably quite close to being so. More importantly,
the degree of decrease in Nipbl expression in Nipbl+/2 mice is
comparable to that which causes CdLS in man. Overall the data
from multiple species strongly argue that pervasive developmental
abnormalities result from remarkably small changes in NIPBL
levels.
Sister chromatid cohesion is not significantly affected in
Nipbl+/2 mice
There has been one report of precocious sister chromatid
separation (PSCS) in cell lines derived from individuals with CdLS
[28], which was not seen in a second study [29]. We found no
statistically-significant elevation of PSCS in cultured Nipbl+/2
MEFs (Figure S3), Nipbl+/2 embryonic stem cells (data not
shown), or adult B-lymphocytes (Figure S3). These results suggest
that cohesion defects in the Nipbl heterozygotes, if present, are very
subtle; they are also in accord with findings in Drosophila, where
PSCS is seen only when both alleles of Nipped-B are mutated [31].
Dysregulation of gene expression in Nipbl+/2 mice
To investigate whether heterozygous loss of Nipbl leads to
alterations in transcription, we turned to expression profiling of
tissues and cells from Nipbl+/2 mice. Because such mice display
pervasive developmental abnormalities, transcriptome data can be
expected to reflect not only the direct consequences of reduced
Nipbl function, but also a potentially large number of transcrip-
tional effects that are secondary consequences of abnormal
morphology and physiology. In an effort to minimize the detection
of such secondary effects, we focused on profiling samples in which
frank pathology was not seen, or had yet to develop by the time of
profiling.
The samples chosen for analysis were embryonic day 13.5
(E13.5) brain, and cultures of fibroblasts derived from E15.5
embryos (mouse embryo fibroblasts; MEFs). Although mature
brain appears to be functionally abnormal in Nipbl+/2 mice (see
above), at E13.5 it at least appears anatomically normal. Cultured
MEFs were chosen because they are established with similar
efficiency from both mutant and wildtype embryos; exhibit similar
Figure 5. Nipbl transcript levels are reduced 25–30% in Nipbl+/2 mice. (A) Autoradiograms showing Nipbl and Gapdh probes, and protected
fragments of 226 (representing Nipbl exons 11 and parts of exons 10 and 12) and 131 bases (Gapdh), respectively. RNA was prepared from livers of
two female littermates (N0 generation; age=119 days). The minor protected band at ,185 bp (corresponding to the size of exon 11) most likely
arises from the presence of unspliced or alternatively spliced mRNA. (B,C) Quantification of Nipbl/Gapdh ratios, from autoradiograms such as in (A), for
adult female liver [(B); age=73 days], and E17.5 brain (C). Mice in each panel are littermates. Hatched bars=wildtype, filled bars=Nipbl+/2. Error
bars=SD for triplicate (B) or quadruplicate (C) measurements.
doi:10.1371/journal.pgen.1000650.g005
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being maintained ex vivo, are freed of the secondary influences of
any systemic metabolic or circulatory derangements within
Nipbl+/2 embryos. Transcriptome analysis was performed using
Affymetrix microarrays. MEF RNA samples were obtained from
10 mutant and 9 wildtype embryos taken from three litters (19
separate microarrays); brain RNA was analyzed from 10 mutant
and 11 wildtype embryos from two litters (21 separate micro-
arrays).
Gene expression changes were detected in both comparisons. In
the brain (Table S2), 1285 probe sets, corresponding to 978 genes,
displayed statistically significant differences in expression between
wildtype and mutant mice (per-probe-set false discovery rate of
Q,0.05). By and large, the effects were small: 97.5% of changes
were within 1.5-fold of wildtype expression values; .99.6% were
within 2-fold. The single largest statistically-significant change was
2.5-fold. Genes encoding products of virtually all structural and
functional categories could be found among those affected, with no
dramatic enrichment of any particular functional sets (by Gene Set
Enrichment Analysis [65]; data not shown).
In cultured Nipbl+/2 MEFs, 89 probe sets, corresponding to 81
genes (Table S3), displayed statistically-significant (Q,0.05)
differences in expression between wildtype and mutant mice.
Again, effects were small: 89% of changes were within 1.5-fold of
wildtype, and 99% were within 2-fold. The single largest
statistically-significant change was 2.1-fold. The lower number of
transcriptional changes identified in MEFs versus brain may not
be biologically meaningful, as MEFs happened to display a
somewhat higher average within-sample variance than E13.5
brain, making it more difficult for small changes to be judged
significant.
As with embryonic brain, transcriptional effects in MEFs
involved genes that encode a wide variety of proteins. Although
automated analyses failed to single out any particular functional
class as being highly overrepresented, manual curation revealed
significant changes in the expression of a number of genes
implicated in adipogenesis (Figure 6A). For example, Cebpb and
Ebf1—which encode transcriptional factors central to the process
of adipocyte differentiation [66–68]—were both down-regulated
in Nipbl+/2 MEFs, as were Fabp4 and Aqp7, well-known adipocyte
markers [69,70]. Other genes down-regulated in Nipbl+/2 MEFs
(Table S3) could also be found, through literature searches, to
exhibit expression positively correlated with adipocyte differenti-
ation, including Adm, Lpar1, Osmr, and Ptx3 [69,71,72]. Several
additional genes (Amacr, Avpr1a, Il4ra, Prkcdp, S100b) down-
regulated in Nipbl+/2 MEFs can be inferred, from publicly-
available expression data, to be enriched in pre-adipocytes and/or
brown or white adipose tissue [73–75]. Conversely, Lmo7, which is
normally down-regulated during late adipogenic differentiation
[71], was found to be up-regulated in Nipbl+/2 MEFs.
Furthermore, we noted that genes such as Cebpa and Cebpd
(transcriptional activators of adipocyte differentiation [66,76]), Il6
(a cytokine stimulator of adipocyte differentiation that controls
adiposity in man [77,78]) and Socs3 (an intracellular signaling
regulator induced by Il6 [79]), were also down-regulated in the
MEF samples, but at false-discovery rates slightly too high to
permit their inclusion in Table S3 (Q=0.065, 0.085, 0.075, and
0.17, respectively).
Figure 6. Alterations in adipogenesis in Nipbl+/2 mice. (A) Gene regulatory network underlying adipogenesis. The adipogenic conversion of
pre-adipogenic mesenchyme is under the control of a network of cross-regulating transcription factors, notably C/EBPb, C/EBPa, C/EBPd, PPARc, and
Ebf1 [67,68,76]. Input into this pathway can come from adipogenesis-promoting growth factors, such as interleukin 6 (IL6), or pharmacological agents
such as glucocorticoids and PPARc agonists [81,82]. A variety of other downstream genes have been identified as markers of early and late
adipogenesis. Genes that were observed to be down-regulated in Nipbl+/2 MEFs are highlighted in blue; those up-regulated are highlighted in pink.
(B,C) Nipbl+/2 mice are depleted in both white and brown fat. Scapular fat pads were dissected from adult male mice (206–630 days postnatal),
divided into brown and white portions, and weighed (B). In (C), these weights have been normalized to brain weight, to correct for overall body size
differences between wildtype (N=11) and mutant (N=9) mice. Both panels indicate that Nipbl+/2 mice are substantially depleted in fat. (*=P,0.05,
**=P,0.01, Student’s t-test). (D–F) Reduced spontaneous adipogenesis in Nipbl+/2 MEFs. To determine whether mutant mesenchymal cells are
intrinsically defective in adipogenic differentiation, wildtype (D) and Nipbl+/2 (E) MEFs were cultured at confluence for 8 days, which allows for
spontaneous adipocyte differentiation by a fraction of the cells, and fat-accumulating cells were visualized by Oil Red O staining. (F) summarizes data
on the fraction of Oil Red O-positive cells observed in 9 independent MEF lines (.21,000 cells counted per line), from 4 wildtype and 5 Nipbl+/2 mice
(P,0.05, Mann-Whitney Rank-Sum test).
doi:10.1371/journal.pgen.1000650.g006
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specifically impaired in adipogenesis. Support for this idea was
obtained by weighing intrascapular fat dissected from adult
mutant and wildtype littermates [80]. As shown in Figure 6B,
both brown and white fat are substantially depleted in Nipbl+/2
mice. To correct for the fact that mutant mice are generally
smaller than their wildtype littermates, we normalized fat
measurements to brain weight (which scales with overall body
size). As shown in Figure 6C, even by this measure, Nipbl+/2 mice
displayed a significant, substantial reduction in body fat. As
mentioned earlier, lean body habitus is also a characteristic of
CdLS.
To investigate whether the reduction in body fat in Nipbl+/2
mice reflects an intrinsic defect in the differentiation potential of
mutant fibroblasts, we studied adipogenic differentiation in vitro.
It is known that embryonic fibroblasts can be converted, in large
numbers, to adipocytes by treatment with agents such as
glucocorticoids, PPAR-c agonists, isobutylmethylxanthine and
insulin, which stimulate the activity of a core network of pro-
adipogenic transcription factors (C/EBPa, C/EBPb, C/EBPd,
PPARc; [81,82]). In response to such agents, we observed no
significant difference between Nipbl+/2 and wildtype MEFs in
terms of the number of adipocytes or adipocyte colonies produced
(data not shown). However, when we omitted these pharmaco-
logical agents, and measured the (much lower) level of spontane-
ous adipogenic differentiation that occurs in MEF cultures [83],
we observed a substantially-lower level in mutant cultures
(Figure 6D–6F). The observation that Nipbl+/2 MEFs are
impaired in spontaneous, but not induced, adipogenesis implies
that their primary defect does not lie downstream of the targets of
pharmacological inducers.
Shared transcriptional effects across tissues
Of the 80 genes (not counting Nipbl itself) with significant
differential expression in Nipbl+/2 MEFs (Table S3), 20% (16/
80) are also found among the 978 genes whose expression was
altered in Nipbl+/2 embryonic brain (Table S2). Using a more
stringent false discovery rate cutoff of Q,0.02 for both
samples, we find that 23% (9/40) of differentially expressed
MEF genes are among the 560 that are differentially expressed
in brain. These data suggest that common transcriptional
targets exist in the two tissues. Further support for this idea is
obtained by correlating fold-increase or -decrease of affected
transcripts. In this case a less conservative approach to false
discovery is justified (the goal is to estimate overall correlation
between samples, not implicate individual genes), so the log-
fold changes for all probe sets that exhibited differential
expression exceeding an arbitrary t-statistic threshold (t.2) in
both tissues were plotted against each other (shown in Figure 7).
The data are clearly strongly correlated (R=0.77), suggesting
that at least some of the transcriptional effects of Nipbl
deficiency are shared across tissues. Among the genes in which
expression changes contributed substantially to the correlation
a r ef o u rm e m b e r so ft h ep r o t o c a d h e r i nb cluster (Pcdh17,
Pcdh20, Pcdh21, Pcdh22; all down-regulated), Lpar1 (also down-
regulated; encoding the lysophosphatidic acid receptor), Vldlr
(down-regulated; encoding a receptor involved in both lipid
m e t a b o l i s ma n dc e r e b r a lc o r t i c a ld e v e l o p m e n t ) ,a n dStag1 (up-
regulated; encoding SA1, a cohesin component). Interestingly,
in Drosophila, inhibition of Nipped-B expression also leads to up-
regulation of the ortholog of Stag1 [31]. Recently, STAG1 up-
regulation has also been seen in lymphoblastoid cell lines of
individuals with CdLS [64; Table S5].
Position-specific effects of Nipbl on protocadherin beta
gene expression
Among the most significant changes common to mutant MEF
and brain samples were decreases in expression of transcripts from
the 22-gene Pcdhb (protocadherin beta) cluster on chromosome 18
(Table S2 and Table S3, Figure 7). As shown in Figure 8A, affected
transcripts included Pcdhb7,16,17,19,20,21 and 22, which lie
predominantly at the 39 end of the cluster. This observation raised
the possibility that the transcriptional effects of Nipbl might be
related to the physical locations of genes. However, as genes at the
59 end of the Pcdhb cluster tend to be expressed at lower levels than
those at the 39 end, lower signal-to-noise ratios might have made
small changes in expression at the 59 end more difficult to detect.
To resolve this issue, and to provide independent confirmation
of microarray data, quantitative RT-PCR was used to measure
transcripts levels at multiple locations throughout the Pcdhb cluster
(Figure 8B). For these experiments, brain mRNA was prepared at
a later developmental stage (E17.5, when most Pcdhb transcripts
are more highly expressed) from 13 independent samples (7
mutant and 6 wildtype embryos). Robust RT-PCR signals were
obtained for 14 of 15 transcripts tested (Pcdhb2,3,4,5,7,8,9,
10,13,14,16,17,19, and 22; but not Pcdhb1). As shown in
Figure 8B, the data support the microarray results from the
earlier embryonic stage, and indicate that most transcriptional
changes in Nipbl+/2 brain indeed occur preferentially at the 39
end of the cluster (Pchdb13,14,15,16,17,19,22). Additionally, they
suggest that at least one 59 gene, Pcdhb2, may also be affected.
Figure 7. Gene expression effects are correlated across cell/
tissue types. Comparison of gene expression profiles of E13.5 brain
and MEFs (cf. Table S2 and Table S3, respectively) identified 25 probe
sets for which differential expression between wildtype and Nipbl+/2
samples displayed a t-statistic with an absolute value .2 in both brain
and MEFs. For each such probe set, the log2-transformed expression
change in MEFs was plotted against the log2-transformed expression
change in brain. Points are labeled by gene symbol. The observed
correlation (correlation coefficient=0.77) indicates that, for those
transcripts affected in both mutant brain and mutant MEFs, the
directions and magnitudes of the expression changes are often similar.
This suggests that such transcripts may be ‘‘direct’’ targets of NIPBL.
Note the presence of Stag1, which encodes a cohesin subunit.
doi:10.1371/journal.pgen.1000650.g007
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correlating Pcdhb transcript levels in each tissue sample,regardless of
genotype, against Nipbl transcript levels within that sample (i.e.
treating Nipbl expression as a quantitative trait; Figure 8C, Figure
S4). This approach offers greater discriminatory power because
Nipbl expression in individual samples varies significantly, even
within mutant and wildtype groups, and occasionally overlaps
between the two groups. Indeed, the results of the analysis indicate
that Pcdhb expression correlates strongly with Nipbl transcript level,
lending support to the view that Pcdhb transcription is directly
affected by the amount of NIPBL present in cells. In Figure 8C, the
results of such correlations for all 13 tested Pcdhb transcripts are
summarized by plotting the slopes of regression lines (the sensitivity
of each transcript’s expression to Nipbl level) against gene location,
with error bars reflecting the strength of correlation for each gene.
Theresults stronglysuggest a continuumofsensitivityto Nipblacross
the entire Pcdhb cluster, with genes at both the 59 and 39 ends being
the most sensitive, and those in the middle being least affected.
Discussion
The Nipbl mutant mouse as a model for Cornelia de
Lange Syndrome
We show here that mice heterozygous for a gene-trap mutation
upstream of the first coding exon of Nipbl displayed many features
of human CdLS, including pre- and postnatal growth retardation,
cardiac septal defects, delayed bone development, lean body
habitus, microbrachycephaly with characteristic craniofacial
changes, behavioral disturbances, ophthalmological abnormalities,
cerebellar hypoplasia, and hearing deficits (Figures 1–4, Table S1,
Videos S1, S2, S3, S4, S5). These phenotypes remained stable
through many generations of outcrossing, and occurred in the
context of modest (25–35%) reductions in levels of Nipbl mRNA in
every tissue measured (embryonic brain, MEFs, adult liver).
Similarly modest reductions have recently been reported in cell
lines derived from individuals with CdLS [63,64].
In some cases, quantitative agreement between the mouse
model and CdLS is remarkable, e.g. fall-off and catch-up in
growth rates during early postnatal life, the upturned nose. Yet
some common features of CdLS are not observed in the mouse
model, such as reduction and fusion abnormalities of the upper
limb, which is seen in up to 30–50% of children with CdLS
(depending on criteria used). The mutant mouse heart also
displays only atrial and not ventricular septal defects, whereas both
occur at similar frequency in CdLS. Mutant mice also display
some pathological features, such as corneal opacities, that are
atypical of CdLS (corneal scarring has been noted, however [58]).
Furthermore, the frequency of perinatal mortality in CdLS is
estimated at about 10% [8], not as high as in the mutant mouse
(although this may simply reflect better postnatal care).
Figure 8. Position-specific effects on beta protocadherin (Pcdhb) expression. (A) The protocadherin beta (Pcdhb) locus consists of 22
tandemly-oriented, single-exon genes distributed over ,250 kb of chromosome 18. The names of genes that displayed significant reductions in
expression in microarray analyses of Nipbl+/2 E13.5 brain, and Nipbl+/2 MEFs, are circled in red, and green, respectively. (B) Quantitative RT-PCR was
used to measure the levels of 14 Pcdhb transcripts in RNA from E17.5 wildtype and Nipbl+/2 brain. Data are averages from 6 wildtype and 7 mutant
samples, presented as percent change from wildtype. (C) Sensitivities of gene expression to Nipbl level. Quantitative RT-PCR results for the Pcdhb
transcripts in (B) were correlated with the levels of Nipbl in each mutant and wildtype sample to produce a best-fit regression line that estimates the
fold-change in Pcdhb transcript per fold-change in Nipbl. Error bars representing the standard error of this estimate were obtained from the 67%
confidence intervals for the slopes of the regression lines (roughly equivalent to one standard deviation; see Figure S4 for details). Sensitivities and
error bars were plotted on an abscissa corresponding to the location of the transcriptional start sites of each of the Pcdhb genes. The dashed line is a
smooth polynomial fit to the data. Note that a sensitivity of unity simply means that a Pcdhb transcript level varies linearly with Nipbl levels, whereas a
sensitivity of 0.2 means it varies with the 1/5
th power of Nipbl levels (i.e. very weakly). The data imply that sensitivity is high at both ends of the Pcdhb
cluster, falling to much lower levels in the middle.
doi:10.1371/journal.pgen.1000650.g008
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an excellent animal model for many features of CdLS, and
provides the first experimental verification that Nipbl mutations
cause the syndrome. Interestingly, wide variation in the pene-
trance or severity of phenotypes, a distinctive feature of CdLS, was
also observed in mutant mice. Because the mouse line was
maintained on an outbred (CD-1) background (given high
mortality of heterozygotes, it was not practical to maintain the
line on an inbred background), genetic heterogeneity could have
accounted for some of the variability.
It is fascinating that the diverse and severe pathology observed in
this study is caused by only a 25–35% decrease in the level of Nipbl
transcripts (Figure 5; also see Table S2 and Table S3). A recent
study of a rare familial case of CdLS involving a mutation in the 59-
untranslated region of NIPBL suggests that a mere 15% decrease in
transcript levels is associated with a clinically significant phenotype
[63]. Given the extraordinary sensitivity of development to the level
of expression of this one gene, it would not be surprising if an
unusually high proportion of disease-causing mutations in Nipbl
occur in regulatory DNA, where they would be difficult to detect.
This could help explain why such a large proportion of CdLS
mutations (,40%) have yet to be identified [23,84,85].
Transcriptional dysregulation in the Nipbl+/2 mouse
Results of the present study support the view that changes in
Nipbl level have significant, yet modest, effects on transcription
throughout the genome. At present, it is impossible to know how
many observed gene expression changes (Table S2 and Table S3)
are primary—due to direct transcriptional actions of NIBPL—and
how many are downstream consequences of gene misregulation.
Among the affected MEF transcripts that were noted to participate
in adipogenic differentiation, for example, many are transcrip-
tional targets of each other (Figure 6A), raising the possibility that
direct actions of NIPBL may be confined to a subset of these.
Among the most likely candidates for direct NIPBL ‘‘targets’’
are those genes that displayed similar expression changes in both
cultured MEFs and E13.5 brain (Figure 7). Prominent among
these were genes of the protocadherin beta (Pcdhb) cluster.
Measurements in later-stage brain confirmed that alterations in
gene expression occur throughout the Pcdhb locus in Nipbl+/2
mice, but in a manner that is positionally graded across the cluster
(Figure 8). Such effects are consistent with a role for NIPBL in the
long-range, coordinated regulation of sets of genes.
Additional evidence for this hypothesis can be found in the
E13.5 brain expression data: As shown in Table S4, there are at
least 13 other examples of small clusters (usually 2–4 genes) of
related (paralogous) genes, in which Nipbl+/2 mice display similar
expression changes in more than one paralog. Two of these are the
well-studied b- and a-globin loci [86], in which long-range cis-
regulatory elements (locus control regions) are known to control
and coordinate expression of different transcripts (the globin
transcripts in brain RNA presumably come from fetal erythrocytes
in the tissue). Interestingly, whereas decreases in expression were
seen at all four b-globin genes in Nipbl+/2 samples, the
magnitudes varied greatly among the genes within each cluster
(arguing against the trivial possibility that Nipbl+/2 brains simply
have less blood in them). In fact, the single greatest gene
expression change in the entire study (,2.5 fold decrease) involved
one of the transcripts (Hbb-bh1) of the b-globin locus.
It is known that the transcriptional insulator protein CTCF plays
an important role in establishing chromatin boundary elements at
the b-globin locus [87]. The Pcdhb locus is also flanked, at least in
man, by sites occupied by CTCF [88], the functional significance of
which has yet to be studied. CTCF insulation is also involved in
control of the myc-locus [89], which is highly significantly down-
regulated in E13.5 Nipbl+/2 brain (Table S2). Even the Igf2/H19
locus, at which long-range, CTCF-dependent regulation of gene
silencing has been shown to occur [90,91], displayed evidence of
H19 down-regulation (by ,20%) in the Nipbl+/2 brain, albeit at
lower statistical significance (Q=0.14).
In view of recent work showing that cohesin and CTCF binding
sites extensively co-localize in the mammalian genome (including at
the b-globin, Igf2/H19 and myc loci [35–37]), and that cohesin
contributes to CTCF function [35,37], it is reasonable to speculate
that at least some of the transcriptional effects in Nipbl+/2 tissues
arise from impaired CTCF function. It should be noted, however,
that CTCF sites are far more common (.13,000 per mammalian
genome) than Nipbl-sensitive genes, and we find no clear correlation
between the locations of Nipbl-sensitive genes (or the magnitudes of
transcriptional effects in those genes) and known or predicted
CTCF-sites (X. Xie and N. Infante, personal communication). It
remains possible that only a subset of NIPBL transcriptional effects
is related to CTCF function. Indeed, it is possible that NIPBL acts
primarily by influencing other aspects of long-range cis-regulatory
interaction (e.g. histone methylation, DNA looping), which simply
take place frequently at CTCF-regulated loci.
Despite the extensive overlap between the phenotypes of
Nipbl+/2 mice and CdLS, it is interesting to note that the gene
expression changes recently reported in lymphoblastoid cell lines
of CdLS individuals [64] exhibit only limited overlap (6–8%; cf.
Table S5) with those we observed in mouse embryo fibroblasts and
embryonic brain (Table S2 and Table S3). So far it is unclear
whether this stems from a high degree of tissue-specificity in the
expression of genes that are directly affected by NIPBL; a high
proportion of indirect NIPBL targets (which might be more likely
to vary from tissue to tissue); or the effects of differences in
genomic organization between mouse and man.
Phenotypic significance of transcriptional changes in the
Nipbl+/2 mouse
Among the gene expression changes detected in Nipbl+/2
MEFs and brain (Table S2 and Table S3) one can find many genes
that, when mutated in mice or man, produce phenotypes that
overlap with CdLS. These include skeletal and craniofacial
abnormalities (Lpar1, Pitx2, Satb2, Tcof1, Trps1); heart defects
(Adm, Cited2, Cxcl12, Gja1, Hey2, Pitx2, Mef2c); reduced body size
(Ebf1, Lpar1, Hsd3b7, Mef2c); decreased adiposity (Cebpb, Ebf1,
Lpar1, Npy, Vldlr); behavioral abnormalities (Avpr1a, Ctnnd2, Lpar1,
Vldlr); seizures (Cdk5r1, Gabrb1, Gabrb2, Neto1, Nr4a3, Plcb1, S100b,
Sv2b); and hearing deficits (Cldn11, Eya, Gjb2, Gjb6) [66,92–124].
For most of the genes mentioned above, however, phenotypes
are observed only with complete loss of gene function. In the few
cases in which significant heterozygous phenotypes are seen (e.g.
Satb2, Pitx2, Trps1, Tcof1, Cited2), expression changes in the same
genes in Nipbl+/2 samples are not even as great as would be
expected for heterozygous loss. Of course, it is possible that greater
expression changes occur at other stages, or in other tissues, than
those sampled here. However, the alternative interpretation is that
phenotypes in Nipbl+/2 mice, and in individuals with CdLS, arise
from the collective effects of small changes in the expression of
many genes. Although we are not yet in a position to distinguish
between these hypotheses, we recognize that this issue is closely
related to a major unanswered question in human genetics:
whether most common disease phenotypes arise from large effects
at a few loci, or from very many loci of small effect. The results of
the present study suggest that further study of CdLS, and related
‘‘cohesinopathies’’ [125,126], could shed light on a fundamental
question of widespread importance.
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Ethics Statement: All animals were handled in strict accordance
with good animal practice as defined by the relevant national and/
or local animal welfare bodies, and all animal work was approved
by the University of California Irvine Institutional Animal Care
and Use Committee (protocol 1998-1656).
A search for Nipbl sequences in mouse gene-trap databases
(http://www.genetrap.org/) initially identified two targeted ES
cell lines (generated using the E14 parental cell line, which has a
129/Ola background). One of these (RRS564) contains a gene-
trap in the intron between exon1 and exon 2; the other (RRJ102)
in intron 25 (the exon numbering of [16] for the human gene is
used here). Gene-trap constructs are designed to terminate
transcription and translation, producing a truncated or absent
protein product. Both cell lines were injected into blastocysts of
C57BL/6 mice (for the RRJ102 cell line, 83 blastocysts were
injected; for RRS564, 324 blastocysts were injected). Multiple
male chimeras were obtained and bred against outbred (CD-1;
Charles River) females. Germ line progeny (distinguishable by
chinchilla coat color) were obtained only from RRS564-derived
chimeras, and further work on RRJ102 was suspended. The
RRS564 allele is hereafter referred to as Nipbl
564 and mice
heterozygous for this allele as Nipbl+/2 for simplicity. Nipbl+/2
mice were maintained under normal laboratory conditions, and
the line propagated by successive rounds of outcrossing to CD-1
mice. Offspring were genotyped using LacZ-(Forward 59-TGAT-
GAAAGCTGGCTACAG-39 and Reverse 59-ACCACCGCAC-
GATAGAGATT-39) primers.
Anatomical and histological evaluations were performed using
fresh-frozen or paraformaldehyde fixed tissues. In some cases,
fixation was carried out by cardiac perfusion. Alcian Blue/Alizarin
Red staining was carried out as described [127]. Hematoxylin-
eosin and cresyl violet staining was carried out using standard
techniques. Micro-CT analysis of adult (.90 days) skulls was
performed using a Scanco VivaCT as described [128,129].
Craniofacial shape was assessed using geometric morphometric
techniques, and cranial vault thickness was assessed in 3D as
described [130,131]. Scapular fat pads were dissected and
measured as described [80]. Auditory brainstem response
recordings were generated as described [62]. Briefly, a cohort of
young adult mutant and littermate control animals were
anesthetized with avertin (2.5% solution of tribromoethanol in
tert-amyl alcohol; 20 ml/g body weight administered by i.p.
injection), and subcutaneous electrodes inserted at the level of the
brainstem to record neural potentials evoked by a variety of clicks
and tones introduced into one ear.
Embryo fibroblasts (MEFs) were cultured from E15.5 Nipbl+/2
and wildtype littermate embryos as described [127]. Metaphase
spreads of MEFs were prepared from cells cultured for 12 hrs in
medium supplemented with 0.1 mg/ml colchicine. Trypsinized
cells were pelleted, incubated in 75 mM KCl for 20 min at 37uC,
then re-pelleted and fixed in 3:1 methanol/acetic acid. Cells were
dropped onto glass slides and stained with 49-6-Diamidino-2-
phenylindole or Giemsa. Microscopic assessment was carried out
for each slide by three independent observers who were blinded to
the genotypes of the sample.
B cells were isolated from mouse spleens by immunomagnetic
depletion with anti-CD43 beads (Miltenyi Biotech), cultured in
RPMI1640 with 10% fetal bovine serum, and stimulated with
lipopolysaccharide (25 mg/ml; Sigma) and IL4 (5 ng/ml; Sigma)
for 3 days. Cells were arrested at mitosis by treatment with 0.1 mg/
ml colcemid (Roche) for 1 hour, and metaphase chromosome
spreads prepared following standard procedures. Cells were
stained with 49-6-Diamidino-2-phenylindole and images of
metaphases acquired with an Axioplan2 upright microscope
(Zeiss), using Metamorph software.
Measurements of Nipbl levels by RNase protection were made
according to standard methods. The Nipbl probe contained 39
bases of exon 10, all 183 bases of exon 11, and 4 bases of exon 12.
There is no expressed sequence tag evidence supporting
alternative splicing of exons 10–11, and in situ hybridization
studies in mouse embryos indicated they are ubiquitously
expressed, so it was felt that this probe would provide a good
indication of overall levels of expression. Briefly, for each reaction,
20 mg of total RNA was hybridized with
32P-labeled probes for
Nipbl (90,000 cpm) and Gapdh (glyceraldehyde 3-phosphate
dehydrogenase; containing 116 bases of exon 4 and 15 bases of
exon 5; 20,000 cpm) and processed according to manufacturer’s
instructions (Ambion RPA III kit). Samples were run on a 5%
polyacrylamide/8M urea gel, dried, and bands quantified by
phosphorimager.
For measurement of NIPBL protein levels, MEFs were lysed in
cold buffer containing 50 mM Tris (pH 7.4), 150 mM NaCl, 1%
Triton X-100, 1% sodium deoxycholate, 0.1% SDS, and protease
inhibitors [1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM
EDTA, 2 mg/ml aprotinin, 2 mg/ml leupeptin, and 2 mg/ml
pepstatin]. Total protein (20 mg) from 3 wildtype MEF homog-
enates and 3 Nipbl+/2 MEF homogenates was separated, in
duplicate, on 7.5% SDS-PAGE gels and transferred onto
Immobilon-P membranes (Millipore, Bedford,MA). The mem-
branes were blocked with 2% BSA and sequentially incubated
with the anti-GAPDH (1:200,000, 6C5; Ambion, Austin,TX) and
anti-NIPBL-N (1:60000, anti-NIPBL antibody was produced in
rabbit from a GST fusion protein containing amino acids 1–380 of
human NIPBL, and was affinity purified using original antigen).
The membranes were then incubated with the horseradish
peroxidase-conjugated anti-rabbit antibody (1:10000) and detected
using chemiluminescence. Images were scanned and densitometry
performed.
To evaluate spontaneous adipogenic differentiation, MEFs
(passage 2) were seeded into 96-well plates at 7,500 cells/well,
maintained in Dulbecco’s modified Eagle’s Medium with 10%
fetal bovine serum, 100 U/ml penicillin and 100 mg/ml strepto-
mycin at 37uC, cultured to confluence, and maintained for 7
additional days. Lipid accumulation was visualized by staining
with Oil Red O. Briefly, cells were washed with PBS and fixed
with 10% formaldehyde (30 minutes at room temperature), rinsed,
and permeabilized in 60% isopropanol for 2–5 minutes. Isopro-
panol was removed and Oil Red O solution (Chemicon,
Temecula, CA) was added for 30 minutes. Wells were washed
several times with PBS then counterstained with Hoechst 33258
(0.01 mg/ml). Four wildtype and five Nipbl+/2 MEF lines were
analyzed. Each was plated in triplicate wells and 7 fields (at 106
magnification) within each well were photographed and lipid-
containing cells (stained lipids appear red under phase contrast)
and nuclei (appear blue with fluorescent microscopy) were counted
using Image J software (NIH) to detect nuclei (nucleus counter
plug-in: approximately 1000–1200 nuclei were detected per field)
and lipid-containing cells (point picker plug-in).
Analysis of gene expression was performed on total RNA
isolated using the trizol method from MEFs, adult liver, or
manually dissected E13.5 brain. Hybridization and data collection
were carried out by the Broad Institute (Cambridge, MA). RNA
was labeled and hybridized to Affymetrix Murine 430A 2.0 (for
MEFs) or 430 2.0 (for brain) array chips using the protocol
described at http://www.broad.mit.edu/mpr/publications/projects/
Leukemia/protocol.html, and data were analyzed using GenePattern
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Expression data sets were assembled from individual CEL files using
the RMA algorithm with quantile normalization. Data were log2-
transformed and transcripts with near-background expression filtered.
Measures of statistical significance were obtained by permutation
testing [132], using the Comparative Marker Selection module.
Significance is presented in terms of per-sample false discovery rates, or
Q-values [133]. Data were also analyzed using D-chip software
(http://www.biostat.harvard.edu/complab/dchip), which yielded sim-
ilar enrichment sets (not shown). Probe sets were annotated, and gene
locations obtained, according tot h eN C B Im 3 7m o u s ea s s e m b l y ,a n d
Affymetrix annotation files ver. 28 (March 2009).
For measurements of transcript abundance by quantitative
PCR, RNA (5 mg) from E17.5 mouse brains was reverse
transcribed with Superscript II, oligo dT, and random hexamers
according to manufacturer’s instructions (Invitrogen, Carlsbad,
CA). Reactions were assembled using iQ SYBR Green Supermix
(BioRad, Hercules, CA) and processed in 20 ml volumes with 1 ml
of cDNA (diluted 1:25) and primers at a final concentration of
100 nM. Specificity of amplification was verified for each reaction
by examination of the corresponding melt curve. Normalization
was carried out using beta-2 microglobulin as a standard, and
genomic amplification controlled for using samples prepared
without reverse transcription. All PCR reactions were performed
on an iQ5 iCycler (BioRad). Cycling conditions were 95uC for
4 min and then 40 cycles of 95uC 10 sec, 61uC 30 sec and 72uC
30 sec. Primers were:
Pcdhb2: agcccacctggtagatgttg and attggggatgattggtttca; Pcdhb3:
cctggaaatacaccgcagaa and cctagacatggacccagcaa; Pcdhb4: cagt-
cagtcccaacctcca and tgaactgtggtcatcccagac; Pcdhb5: cagaggggaaat-
caggaaca and gggcttaaactggcaatgaa; Pcdhb7: accccacacaggaagttgag
and ctttatccccacgaaaagca; Pcdhb8: gccttggcttctgtgtcttc and caccact-
gacatccaccaag; Pcdhb9: atgcctggtgaacactttcc and gcagtggggactttc-
cataa; Pcdhb10: gctgaccctcacctctcttg and accaccacgagtaccaaagc;
Pcdhb13: ggcttctctcagccctacc and cagcaccacagacaagagga; Pcdhb14:
cattgcacataggcaccatc and tgatggagatgagcgagttg; Pcdhb16: tggcttc-
tctcagccctacc and aacagcagcacagacaccag; Pcdhb17: gcaagtcctgg-
ctttctttg and ggatatctctgccaggtcca; Pcdhb19: gacaaggcaagtcctgcttc
and ccccaggtcctttaccaaat; Pcdhb22: tatcatcgctcaccaatcca and ca-
gagctccatctgtcacca, beta-2-microglobulin :, atgggaagccgaacatactg and
cagtctcagtgggggtgaat, and Nipbl (exons 6–7): agtccatatgccccacagag
and accggcaacaataggacttg. PCR product sizes were between 107
and 182 bp.
Supporting Information
Figure S1 The Nipbl gene trap allele. (A) The Nipbl gene consists
of 47 exons, distributed over 150 kbp on Chromosome 15. The
Nipbl
564 allele inserts a b-geo gene trap cassette within intron 1. (B)
Nipbl exon 1 forward primer and b-geo reverse primer [arrowheads
in (A)] detect Nipbl-b-geo fusion mRNA in reverse-transcribed RNA
from Nipbl
564 ES cells (lane 1). No signal is detected in wildtype ES
cells (lane 2). The structure of the fusion RNA was confirmed by
sequencing. Lane M=100 bp DNA ladder.
Found at: doi:10.1371/journal.pgen.1000650.s001 (0.24 MB TIF)
Figure S2 NIPBL protein levels in E15.5 Nipbl+/2 MEFs.
Immunoblot comparing levels of NIPBL protein in wildtype (+/+)
and Nipbl+/2 MEFs. Protein extracts from MEF cultures
established from 2 wildtype and 2 Nipbl+/2 mice were subjected
to electrophoresis, blotted, and probed with an antibody directed
against the N-terminus of the human NIPBL protein (see Materials
and Methods). Immunoblotting for Gapdh served as a protein
loading control. Densitometric analysis revealed that NIPBL
protein was reduced by 27% in Nipbl+/2 MEFs.
Found at: doi:10.1371/journal.pgen.1000650.s002 (0.16 MB TIF)
Figure S3 Assessment of sister chromatid cohesion in Nipbl+/2
cells. (A) Metaphase spreads of cultured MEFs were scored
according to which of the following characterized the greatest
proportion of chromatids: separated (completely separated with no
connection at the centromere); loosened (connected only at the
centromere); and closed (no gap; chromatids remain connected).
Data are expressed as mean6S.E.M. for $100 metaphase spreads
prepared from 2 independent lines of MEFs of each genotype. No
significant differences in category frequency were observed
between genotypes. (B) Metaphase spreads of cultured B-
lymphocytes were analyzed for sister chromatid cohesion as in
(A). Of 89 wildtype and 147 Nipbl+/2 metaphase spreads, from
spleen cells of two wildtype and three Nipbl+/2 animals, no
examples of loosened or separated chromatids were seen.
Representative examples of wildtype (+/+) and Nipbl+/2 images
are shown.
Found at: doi:10.1371/journal.pgen.1000650.s003 (0.55 MB TIF)
Figure S4 Position-specific effects on beta protocadherin (Pcdhb)
expression. Quantitative PCR was used to measure levels of Nipbl
and Pcdhb transcripts in RNA samples of E17.5 brain from 6
wildtype and 7 Nipbl+/2 mice. Normalized crossing point
threshold values (DCt) for each Pcdhb transcript were plotted
against DCt values for Nipbl (wildtype=black; mutant=red), and
linear regression lines were calculated along with 95% confidence
intervals (dashed curves) around those lines. Panels show data for
Pcdhb2, 3, 4, 5, 7, 8, 9, 10, 13, 14, 16, 17, 19 and 22. The slope of
each regression line corresponds to the input-output sensitivity
[134], i.e. the fold change in Pcdhb transcript for any given fold
change in Nipbl. r=correlation coefficient.
Found at: doi:10.1371/journal.pgen.1000650.s004 (8.40 MB EPS)
Table S1 Structural phenotypes in Nipbl+/2 mice, and
comparable clinical findings in CdLS. Mouse data are presented
as percent of affected animals for each genotype (Wildtype,
Nipbl+/2) and the number of mice assessed (N). Data are pooled
for five generations (N0–N4). The incidence of comparable clinical
findings in CdLS is listed in the right-hand columns.
Found at: doi:10.1371/journal.pgen.1000650.s005 (0.07 MB PDF)
Table S2 Gene expression changes in embryonic day 13.5
Nipbl+/2 brain. Fold changes and per-probe-set false discovery
rates (Q-values) were calculated as described (see Materials and
Methods). Data were obtained from 10 mutant and 11 wildtype
samples. Abs(Score)=the absolute value of the t-test statistic for
each sample. Q-value=per-entry false discovery rate. Among the
1182 probe sets with Q,0.05, there are 978 independent genes.
Among the 751 probe sets with Q,0.02, there are 560
independent genes.
Found at: doi:10.1371/journal.pgen.1000650.s006 (0.27 MB
XLS)
Table S3 Gene expression changes in Nipbl+/2 MEFs. Fold
changes and per-probe-set false discovery rates (Q-values) were
calculated as described (see Materials and Methods). Data were
obtained from 10 mutant and 9 wildtype samples. Abs(Score)=the
absolute value of the t-test statistic for each sample. Q-value=
per-entry false discovery rate. Among the 89 probe sets with
Q,0.05, there are 81 independent genes. Among the 43 probe
sets with Q,0.02, there are 40 independent genes.
Found at: doi:10.1371/journal.pgen.1000650.s007 (0.03 MB
XLS)
Table S4 Paralog clusters that display altered expression in the
E13.5 Nipbl+/2 brain. Expression data from E13.5 brain were
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affected in the Nipbl+/2 mutant. In addition to the 22-gene
protocadherin beta locus (see Figure 7), there were 13 cases of two-to-
four paralog clusters exhibiting significant transcriptional changes.
Data are shown for all the paralogs in each cluster, and for any
interspersed non-paralogous genes lying within such clusters, for
which data were available (i.e. informative probe sets existed, and
expression was above background). In all but one case, gene
expression changes among genes within a cluster were always in
the same direction. Two of the clusters (the alpha- and beta-globin
loci) are well-known locus control regions (see text).
Found at: doi:10.1371/journal.pgen.1000650.s008 (0.04 MB PDF)
Table S5 Genes displaying expression changes in both Nipbl+/2
mice (this study) and CdLS lymphoblastoid cell lines [64]. Gene
symbols refer to human loci. Where the standard symbols for mouse
orthologs are not identical, the mouse symbol is given in parentheses.
Found at: doi:10.1371/journal.pgen.1000650.s009 (0.05 MB PDF)
Video S1 Circling behavior of Nipbl+/2 mice. Videos S1, S2,
and S3 contrast the repetitive daytime circling behavior displayed
by two sibling Nipbl+/2 mice (Videos S1 and S2) with those of a
wildtype littermate (N1 generation, Video S3). Circling behavior
was consistently more pronounced for the animal in this video
than in the one in Video S2.
Found at: doi:10.1371/journal.pgen.1000650.s010 (6.07 MB
MOV)
Video S2 Circling behavior of Nipbl+/2 mice. Videos S1, S2,
and S3 contrast the repetitive daytime circling behavior displayed
by two sibling Nipbl+/2 mice (Videos S1 and S2) with those of a
wildtype littermate (N1 generation, Video S3).
Found at: doi:10.1371/journal.pgen.1000650.s011 (5.81 MB
MOV)
Video S3 Behavior of a wildtype littermate. Videos S1, S2, and
S3 contrast the repetitive daytime circling behavior displayed by
two sibling Nipbl+/2 mice (Videos S1 and S2) with those of a
wildtype littermate (N1 generation), shown in this video.
Found at: doi:10.1371/journal.pgen.1000650.s012 (5.08 MB
MOV)
Video S4 Limb-clasping behavior. Videos S4 and S5 contrast
the limb-clasping behavior (especially of hindlimbs) displayed by
15% of Nipbl+/2 mutants when suspended by their tails (this
video) with the limb-spreading displayed by nearly all wildtype
mice (Video S5).
Found at: doi:10.1371/journal.pgen.1000650.s013 (1.27 MB AVI)
Video S5 Behavior of a wildtype littermate. Videos S4 and S5
contrast the limb-clasping behavior (especially of hindlimbs)
displayed by 15% of Nipbl+/2 mutants when suspended by their
tails (Video S4) with the limb-spreading displayed by nearly all
wildtype mice (this video).
Found at: doi:10.1371/journal.pgen.1000650.s014 (0.89 MB AVI)
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